Упрощенная HTML-версия
141
170
Kuiper, G.G. Comparison of the ligand binding specificity and transcript tissue
distribution of estrogen receptors alpha and beta / G.G. Kuiper, B. Carlsson, K.
Grandien et al. // Endocrinology. – 1997. – Vol. 138. – P. 863-870.
171
Kupferer, E.M. Complementary and alternative medicine use for vasomotor
symptoms among women who have discontinued hormone therapy / E.M.
Kupferer, S.L. Dormire, H. Becker // J Obstet Gynecol Neonatal Nurs. – 2009. –
Vol. 38, N 1. – P. 50-59.
172
Kupperman, H. Contemporary therapy of the menopausal syndrome / H.
Kupperman, B. Wetchler, M. Blatt // J. Amer. Med. Ass. – 1959. – Vol. 171, N
12. – P. 103/1627-112/1636.
173
Kurtz, E.G. Oral postmenopausal hormone therapy, C-reactive protein, and
cardiovascular outcomes / E.G. Kurtz, P.M. Ridker, L.M. Rose et al. //
Menopause. – 2011. – Vol. 18, N 1. – P. 23-29.
174
Kushida, K. Comparison of markers for bone formation and resorption in
premenopausal and postmenopausal subjects, and osteoporosis patients / K.
Kushida, M. Takahashi, K. Kawana, T. Inoue // J Clin Endocrinol Metab. –
1995. – Vol. 80, N 8. – Р. 2447-2450.
175
Lee, S.A. An overview of menopausal estrogen-progestin hormone therapy and
breast cancer risk / S.A. Lee, R.K. Ross, M.C. Pike // British Journal Cancer. –
2005. – Vol. 92, N 11. – P. 2049-2058.
176
Lee, S.J. Neurotrophic and neuroprotective actions of estrogens and their
therapeutic implications / S.J. Lee, B.S. McEwen // Annu Rev Pharmacol
Toxicol. – 2001. – Vol. 41. – P. 569-591.
177
Lehmann-Willenbrok, E. Clinical and endocrinologic studies of the treatment of
ovarian insufficiency manifestations following hysterectomy with intact adnexa /
E. Lehmann-Willenbrok, H.H. Riedel // Zentralbl Gynakol. – 1988. – Vol. 110,
N 10. – P. 611-618.
178
Losordo, D.W. Estrogen and angiogenesis / D.W. Losordo, J.M. Isner //
Arteriosclerosis, Thrombosis, and Vascular Biology. – 2001. – Vol. 21, N 6. – Р.
463-471.
179
Luyer, M.D.P. Prospective Randomized Study of Effects of Unopposed Estrogen
Replacement Therapy on Markers of Coagulation and Inflammation in
Postmenopausal Women / M.D.P. Luyer, S. Khosla, W.G. Owen, V.M. Miller //
J Clin Endocrinol Metab. – 2001. – Vol. 86, N 8. – P. 3629-3634.
180
Lyons, R.A. SF-36 scores vary by method of administration: implications for
study design / R.A. Lyons, K. Wareham, M. Lucas // J. Pub. Health Medicine. –
1999. – Vol. 21. – P. 41-45.
181
Lyritis, G.P. Bone anabolic versus bone anticatabolic treatment of
postmenopausal osteoporosis / G.P. Lyritis, T. Georgoulas, C.P. Zafeiris // Ann
N Y Acad Sci. – 2010. – Vol. 1205. – P. 277-283.
182
MacNaughton, J. Age related changes in follicle stimulating hormone,
luteinizing hormone, oestradiol and immunoreactive inhibin in women of
reproductive age / J. MacNaughton, M. Banah, P. McCloud et al. // Clin